Pharmacokinetic (PK) and Safety Study of Iptacopan (LNP023) in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Matched Control Healthy Participants With Normal Hepatic Function.
Clinical trial NCT05078580 · COMPLETED
Trial details
- NCT number
- NCT05078580
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-10
- Primary completion
- 2022-06-20
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.